Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05800600
Status:
RECRUITING
Last Update Posted:
2023-08-24
First Post:
2023-03-24
Brief Title:
Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
Sponsor:
Fox Chase Cancer Center
Organization:
Fox Chase Cancer Center
Study Overview
Official Title:
Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Iron-RANC
Brief Summary:
This is an open-label single institution study evaluating the efficacy of intravenous iron sucrose monotherapy in patients with thoracic breast GU and GI malignancies undergoing neoadjuvant chemotherapy with the goal of undergoing surgical resection
Detailed Description:
This is an open-label single institution study evaluating the efficacy of intravenous iron sucrose monotherapy in patients with thoracic breast GU and GI malignancies undergoing neoadjuvant chemotherapy with the goal of undergoing surgical resection The concomitant use of radiation and immunotherapy as part of the neoadjuvant protocol is allowed in this protocol The study is designed to evaluate the efficacy of iron infusions in reducing blood transfusion frequency and improving hemoglobin levels prior to surgical intervention
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| HM-213 | OTHER | Fox Chase Cancer Center | None |